Drug · DIN 02382105
TEVA-ELETRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 20, 2013; first marketed December 20, 2013.
- Drug Identification Number (DIN)
- 02382105
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Eletriptan N02CC06
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELETRIPTAN (ELETRIPTAN HYDROBROMIDE) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 12, 2013: NOC 14287Abbreviated New Drug Submission (ANDS)
Other DINs named TEVA-ELETRIPTAN
- DIN 02382091 · Marketed